Ardelyx, Inc.
NASDAQ:ARDXBiotechnology
-$0.06 today
- Market cap
- $784.28M
- Beta
- 0.58
- P/E (TTM)
- -24.5
- EPS (TTM)
- -$0.24
Volume 4.75M
Average 3.58M
ARDX Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Ardelyx, Inc.NASDAQ: ARDX
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income remains negative
Q1 FY2026 operating income was -$32.79M, compared with -$36.35M a year earlier. Trailing-twelve-month operating income was -$37.42M.
Context
- Operating income amounted to 10.1% of revenue in FY2025, up 1.7 pp from a year earlier.
- Operating income grew in size in 1 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 8 analysts of -$29.45M (+28.1%) for the fiscal year ending Dec 2026, a step up from the -46.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$32.79M-743.1% QoQ
- Last fiscal yearDec 2025
- -$40.98M-46.6% YoY
- LTMMar 2026
- -$37.42M+5.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +9.8% | +20.8% | +11.0 pp |
| 1 year | -46.6% | +28.1% | +74.7 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- (40.98M) USD
- Year-over-year change
- -46.6%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (40.98M) | -46.6% |
| FY2024 | 2024-12-31 | (27.95M) | +55.8% |
| FY2023 | 2023-12-31 | (63.28M) | +0.8% |
| FY2022 | 2022-12-31 | (63.76M) | +58.7% |
| FY2021 | 2021-12-31 | (154.35M) | — |
Operating Income vs competitors
How ARDX compares with its peers on the latest reported figures
- ARDX's LTM Mar 2026 operating income of -$37.42M is the 4th highest of the 5 companies compared; the peer median is -$15.72M.
- Its year-over-year change of +5.6% is the 3rd highest of 5, against a peer median of +48.9%.
- Operating income amounts to 8.7% of revenue for ARDX, versus a peer median of 11.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $35.9M | +259.6% | — | 11.4% | |
| LTM Mar 2026 | $5.29M | +124.0% | — | 2.3% | |
| LTM Mar 2026 | -$36.74M | -26.3% | — | — | |
| LTM Mar 2026 | -$37.42M | +5.6% | — | 8.7% | |
| LTM Mar 2026 | -$134.05M | -367.0% | — | 670.3% | |
| Peer median (excluding ARDX) | -$15.72M | +48.9% | — | 11.4% | |
Competitors are the stored peer set for ARDX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 10.1M | 52.16M | 124.46M | 333.62M | 407.32M |
| Cost of Revenue | 1M | 4.12M | 17.8M | 50.56M | 42.6M |
| Gross Profit | 9.1M | 48.04M | 106.66M | 283.06M | 364.72M |
| Gross Margin | 90.1% | 92.1% | 85.7% | 84.8% | 89.5% |
| Research & Development | 91.14M | 35.2M | 35.54M | 52.32M | 68.47M |
| Selling, General & Admin | 72.3M | 76.6M | 134.4M | 258.69M | 337.23M |
| Operating Expenses | 163.44M | 111.8M | 169.94M | 311.01M | 405.7M |
| Depreciation & Amortization | 2.81M | 1.14M | 1.29M | 2.06M | 3.06M |
| EBITDA | (150.85M) | (60.98M) | (55.35M) | (16.71M) | (29.17M) |
| EBITDA Margin | -1494.0% | -116.9% | -44.5% | -5.0% | -7.2% |
| Operating Income | (154.35M) | (63.76M) | (63.28M) | (27.95M) | (40.98M) |
| Operating Margin | -1528.6% | -122.2% | -50.8% | -8.4% | -10.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.5M | 5.07M | 8.87M | 20.09M | 28.4M |
| Other Income / Expenses | (3.82M) | (3.44M) | (2.24M) | (10.92M) | (19.65M) |
| Income Before Tax | (158.16M) | (67.2M) | (65.52M) | (38.87M) | (60.63M) |
| Pre-Tax Margin | -1566.4% | -128.8% | -52.6% | -11.7% | -14.9% |
| Income Tax Expense | 4K | 8K | 547K | 266K | 969K |
| Net Income | (158.17M) | (67.21M) | (66.07M) | (39.14M) | (61.6M) |
| Net Margin | -1566.5% | -128.9% | -53.1% | -11.7% | -15.1% |
| EPS (Basic) | (1.52) | (0.42) | (0.30) | (0.17) | (0.26) |
| EPS (Diluted) | (1.52) | (0.42) | (0.30) | (0.17) | (0.26) |
| Weighted Avg Shares | 104.21M | 158.69M | 219.33M | 235.23M | 241.03M |
| Weighted Avg Shares (Diluted) | 104.21M | 158.69M | 219.33M | 235.23M | 241.03M |
Ardelyx, Inc.
NASDAQ:ARDX
Intrinsic Alpha fair value
Locked
Current Price
$3.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.